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The three major United Nations international drug control conventions set a supportive
and complementary system to effectively control the production (manufacture), trafficking
and abuse of drugs. In response to the spirit of the United Nations drug control treaties,
Taiwan has instituted a framework of classification administration and license issuance.
There is also circulation control for managing the diversion of controlled drugs from
pharmaceutical plants and medical institutions, as well as the use of controlled drugs
among pharmaceutical and medical professionals under the Controlled Drugs Act. Most of
the controlled drug registration licenses and prescription licenses issued by the Taiwan
Food and Drug Administration by the end of 2011 were for clinics (7186) and physicians
(39,329), respectively. This article examines the results of the inspection from 2002 to 2011
on controlled drugs carried out by the Taiwan Health Department. A total of 2254 violations
from 159,494 inspections were reported, resulting in a non-compliance rate of 1.41%. The
majority of the violations involved a failure to keep correct records in the controlled drug
logs. The failure to report as regulated the inventory status by registrants increased in the
past decade. On the contrary, there was a significant decrease in the failure to keep records
of the inventory status of controlled drugs over the same period. In addition, the inap-
propriate prescription of controlled drugs has become a growing concern. The findings
revealed that not only diversion, but also abuse of controlled drugs is a major concern in
Taiwan. Finally, it is important to develop educational programs and practice guidelines to
help physicians prescribe appropriately, as well as to prevent diversion and abuse.
Copyright ª 2013, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.Open access under CC BY-NC-ND license.1. Introduction being diverted for illegal uses, and prohibiting illicit traffic andBecause of the highly addictive nature of controlled drugs,
there is the potential for iatrogenic addiction if medical
personnel fail to carefully assess the necessity for the use of
controlled drugs [1]. It is therefore essential that government
policy promotes the rational use of controlled drugs for
medical and scientific purposes while preventing them froministration, Department o
. Tsay).
ministration, Taiwan. Publabuse [2e5].
To safeguard public health as a result of illicit circulation
concerning controlled drugs, the Taiwan government has
promulgated the Controlled Drugs Act (CDA) by following the
three UnitedNations drug conventions on June 2, 1999 [6e9]. A
management system to classify controlled drugs, to trace drug
use and to control circulation was set up. Documentation andf Health, Executive Yuan, 161-2, Kuen Yang Street, Nangang 115,
ished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
Table 1 e Controlled drugs registration licenses (until
December 2011).
Registrant type No.
registered
(% of total)
Total no.a
(% of total)
Hospital 491 (3.57) 491 (100.00)
Clinic 7186 (52.22) 17,217 (41.73)
Pharmacy 4296 (31.22) 7699 (55.79)
Manufacturer 133 (0.97) 268 (49.62)
Distributor 481 (3.50) 5352 (8.98)
Veterinary institution 839 (6.10) 1459 (57.50)
Other 334 (2.42) e
Total 13,760 (100.00) e
a Statistics of General Health.
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provisions to govern measures concerning the use, prescrip-
tion, export, import, manufacture, sale, and control of such
drugs. The Taiwan Food and Drug Administration (TFDA) has
developed a controlled drugs management information sys-
tem (CDMIS), and institutions and businesses use online
reporting for more efficient control of drug flows for health
departments. Likewise, the U.S. has a system of scheduling,
quotas, record-keeping, reporting, and security requirements
to restrict the manufacturing, distributing, and dispensing of
controlled substances, and monitor the flow of controlled
substances from their point of manufacture to the point of
sale or distribution at the dispensing/retail level through an
automated reports and consolidated orders system [11,12].
The TFDA works with medical specialty organizations to
develop evidence-based clinical guidelines that establish best
practices for practitioners such as authorized physicians,
dentists, and others on the rational use of controlled drugs.
This study aimed to examine the results of inspections on
controlled drugs upon all registrants complying with the CDA
and its regulations from 2002 to 2011 in Taiwan. Changes in
violation patterns over the past 10 years were also evaluated
to explore new strategies on the management of controlled
drugs.Table 2 e Prescription licenses for the use of Schedules2. Methods
Controlled drugs are defined as addictive narcotic drugs,
psychotropic drugs, and other drugs deemed to require
enhanced management promulgated by the Executive Yuan
[13,14]. The TFDA develops controlled drug inspection and
management work plans for verifying information from
record-keeping, reporting, dispensing, and security of the said
controlled drugs from the registrants every year. In addition to
supervising local health departments for routine inspections,
the TFDA screens for those who purchase unusual amounts of
controlled substances, have a history of violations or provide
incomplete information of controlled drugs, and joins with
local health departments for intensified inspections. Cases
involving the improper prescription of controlled drugs for
medical use found on inspections are examined by the Review
Committee for the Medical Use of Controlled Drugs under the
TFDA consisting of experts and academics [15]. All results of
joint inspections on controlled drugs by local health de-
partments and the TFDA are entered into the CDMIS and
violation statistics are published annually by the Department
of Health. All the data in this study were collected from the
CDMIS from 2002 to 2012.1e3 controlled drugs (until December 2011).
Registrant type No. of registrants
(% of total)
Total no. of
practitioners a
(% of total)
Physician 39,329 (88.37) 39,960 (98.42)
Dentist 3279 (7.37) 11,992 (27.34)
Veterinarian 1696 (3.81) 3489 (48.60)
Assistant veterinarian 201 (0.45) 493 (40.77)
Total 44,505 (100.00) e
a Statistics of General Health.3. Results and discussion
3.1. License issuance
To confirm the use and to control the circulation of controlled
drugs, businesses, institutions or individuals who import,
export, manufacture, sell, purchase or use controlled drugs
must apply for a controlled drug registration license or pre-
scription license for Schedules 1e3 controlled drugs in Taiwan[16]. As of December 31, 2011, the number of controlled drug
registration licenses totaled 13,760, including 491 hospitals,
7186 clinics, 4296 pharmacies, 133 manufacturers, 481 dis-
tributors, 839 veterinary institutions, and others (Table 1). Of
the 44,505 prescription licenses for the use of Schedules 1e3
controlled drugs, 39,329 were owned by physicians, 3279 by
dentists, and 1897 by veterinarians and assistant veterinar-
ians (Table 2) [17].
The use of controlled drugs is mainly for medications and
animal treatment. In Taiwan, the numbers of registration li-
cense and prescription license holders increased 1.2 (13,760/
11,528) and 1.5 (44,505/29,804) times from 2002 to 2011
respectively. The growth of controlled drug registration also
showed the same tendency in the United States. According to
the Drug Enforcement Administration (DEA), there were more
than 1.3 million individuals and companies in the United
States that registered to handle controlled substances or
regulated chemicals. The overall registrant population
increased 1.2 times from July 2007 to May 2011 as reported by
the DEA (1,388,238/1,241,682) [18,19]. In response to this
growing registrant population, the DEA increased the fre-
quency of scheduled inspections [20].3.2. Inspection results
As required by the CDA, local health departments conduct
field inspections at least biennially, checking the use and
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Fig. 1 e The five major violations found on field inspections on controlled drugs, 2002e2011.
Table 3 e Top 10 violations found on field inspections on controlled drugs, 2002e2011.a
Violation\Category Hospital Clinic Pharmacy Manufacturer Distributor Veterinary
institution
Other Total
Number (%)
Failure to keep correct records in the logs 84 (10.29) 452 (55.39) 222 (27.21) 11 (1.35) 16 (1.96) 29 (3.55) 2 (0.25) 816 (100)
Failure to report inventory status 25 (5.37) 193 (41.50) 172 (36.99) 19 (4.09) 32 (6.88) 19 (4.09) 5 (1.08) 465 (100)
Failure to keep records of the inventory status 26 (7.47) 179 (51.44) 110 (31.61) 8 (2.30) 10 (2.87) 12 (3.45) 3 (0.86) 348 (100)
Non-pharmacist dispensing of controlled drugs 1 (0.61) 160 (97.56) 1 (0.61) 0 1 (0.61) 0 1 (0.61) 164 (100)
Improper prescription of controlled drugs for
medical use
39 (24.22) 121 (75.16) 1 (0.62) 0 0 0 0 161 (100)
Failure to fill in the use of controlled drugs
in the medical record
9 (6.34) 131 (92.25) 0 0 0 0 2 (1.41) 142 (100)
Failure to follow GDP 0 17 (11.97) 117 (82.40) 0 5 (3.52) 0 3 (2.11) 142 (100)
Failure to fill the special prescription form in
prescribing Schedules 1e3 controlled drugs
19 (18.81) 77 (76.24) 2 (1.98) 0 0 0 3 (2.97) 101 (100)
Failure to keep disposal records of surplus
stock of controlled drugs
26 (35.14) 38 (51.35) 8 (10.81) 0 0 2 (2.70) 0 74 (100)
Failure to have the recipient sign the special
prescription form
5 (9.62) 26 (50.00) 21 (40.38) 0 0 0 0 52 (100)
GDP ¼ good dispensing practice.
a An offender might have more than one violation on each inspection.
Table 4 e Case number and rate of violation by registrant
type on field inspections on controlled drugs, 2002e2011.
Registrant No. of
violations
No. of
inspections
Rate (%)
Hospital 190 4555 4.17
Clinic 1128 81,952 1.38
Pharmacy 667 50,888 1.31
Manufacturer 49 1394 3.52
Distributor 95 10,828 0.88
Veterinary institution 62 4746 1.31
Other 63 5131 1.23
Total 2254 159,494 1.40
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stock logged and the actual quantity in inventory, to monitor
circulation and to prevent misuse or abuse [21]. In total, the
health departments carried out controlled drug field in-
spections in 159,494 establishments between 2002 and 2011
and found 2254 violationsda violation rate of 1.4%. Compared
to the United States, the DEA reported (before it discontinued
the measure) that compliance rates fluctuated between 88.5%
and 97.7% between 2003 and 2008 [18].
Among the violations in Taiwan, the majority was incor-
rect record-keeping, totaling 816 cases, followed by failure to
report inventory status, and failure to keep records of the in-
ventory status (Table 3). From 2002 to 2011, the failure to keep
correct controlled drug logsmade up the highest percentage of
violations (20e35%). This was due to some new registrants
with regulatory requirements (Fig. 1). The trend showed a
great increase in the percent of total violations for the failure
to report as required the inventory status of controlled drugs,up to 23.6% in 2011. As license holdersmust report to the TFDA
through the CDMIS starting in 2002, this was the result of the
health departments’ enforcement. In contrast, there was a
significant decrease in the failure to keep records of the
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Fig. 2 e The six major violations of clinics found on field inspections on controlled drugs, 2002e2011.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 1 ( 2 0 1 3 ) 1 3 1e1 3 5134inventory status from 33% to 3.3% between 2002 and 2011. The
high percentage at the beginning of this periodmay have been
due to registration license holders being unfamiliar with the
regulations for keeping accurate records of the manufacture,
sale, dispensing, and prescribing of controlled drugs when the
controlled drug license system was implemented in 2000. For
this reason, health departments held workshops for license
holders on the use of the CDMIS, which seem to have led to
this decreasing trend.
3.3. Inspection results by registrant type
By category of business, hospitals (4.17%) accounted for the
highest proportion of violations, followed by manufacturers
(3.52%) and clinics (1.38%) (Table 4). The main violation of
hospitals was the failure to keep correct records in the
controlled drug logs while many medications were prescribed
and dispensed. However, the most common violation of
manufacturers and distributors was the failure to report
acquisition or distribution transactions monthly.
According to the top five violations by registrant type,
clinics were the major violator in the past decade in Taiwan.
These violations were the failure to keep correct records in the
controlled drug logs (55.39%), failure to report the inventory
status (41.50%), failure to keep records of the inventory status
(51.44%), non-pharmacist dispensing of controlled drugs (160/
164, 97.56%), and improper medical prescription of controlled
drugs (75.16%) (Table 3). Among the top five types of total vi-
olations, the failure to fill the use of controlled drugs into the
medical record was the only difference between clinics and
other registrants.
3.4. The tendency of violations at clinics
The three types of violations at clinics were the failure to keep
correct records in the controlled drug logs, failure to report the
inventory status, and failure to keep records of the inventory
status. It is possible that physicians also served as the
controlled drugs manager in the clinics while they are unfa-
miliar with the relevant provision of controlled drugs. From
2002 to 2011, the failure to keep correct records in thecontrolled drug logs comprised the highest percentage of total
violations (24e37%) at clinics (Fig. 2). There was an increase in
the percentage of total violations for failure to report as
required the inventory status of controlled drugs until 2008
and a decrease after that. In addition, there was a decrease in
the percent of failure to keep records of the inventory status
from 26.6% in 2002 to 4.5% in 2011.
However, it is noteworthy that clinics were the major regis-
trant type found to be improperly prescribing controlled drugs
recently with a violation rate of 20% in 2011, by the monitoring
and inspection policy of sedativeehypnotics. The physicians
involved allowed patients to purchase the drug at their own
expense, with dosages exceeding the medical norm. This is an
indication that the improper prescription of sedativeehypnotic
drugs has increased. For this reason, the TFDA has launched an
Intensified SedativeeHypnotics Inspecting Plan on hospitals,
clinics and pharmacies that have been prescribing/dispensing
largerorabnormalquantitiesof sleep-aidingcontrolleddrugs. In
2011, theTFDA found15casesof impropermedical prescription,
11 of which were zolpidem prescriptions.
This study revealed that violationswere related to registrant
type and government drug control policy. From the inspection
program, there is a need to establish training workshops for
medical and health personnel to have the necessary skills to
carry out their responsibilities on controlled drug use and
management, and to set up guidelines concerning rational use
of controlled drugs for physicians in their clinical practice.r e f e r e n c e s
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